Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Reducing Stress Boosts Efficiency of Bacterial Factories

Unconventional Genetic Strategy Could Enhance Production of Medical Treatments

By Brandon Levy

Tuesday, March 23, 2021

E. coli bacteria

Image credit: Janice Haney Carr, U.S. Centers for Disease Control and Prevention

Recent IRP research details a new strategy that could make genetically modified E. coli bacteria, and possibly other microbes, better at producing medicines and other important substances.

We all have bad days on the job — your colleague keeps bugging you, your boss yelled at you for an innocent mistake, and you skipped lunch because you have five different deadlines coming up. Understandably, many people find it much harder to get their work done under such stressful circumstances. Microbes that produce chemicals for medicine and scientific research experience similar struggles, but a recent IRP study has found that short-circuiting their stress response makes them far more efficient at that task.1

Single-celled organisms like fungi and bacteria produce many substances used for medical treatment or as key ingredients in vaccines, as well as molecules that scientists need for their research. To get microbes to manufacture these products, known as biologics, scientists insert genes into them that cause them to make the chemicals. Over time, researchers have found ways to get each microbial cell to produce more of these molecules, whether by optimizing the conditions in which the cells are grown or through genetic manipulations that rev up the cellular systems involved in protein synthesis.

Perhaps unsurprisingly, microbes don’t particularly like it when we hijack their protein production systems. In fact, forcing microorganisms to make a substance they would not normally produce triggers a stress response that impairs both their ability to grow and their capacity to carry on their molecular manufacturing. This occurs because stress switches on certain genes that suppress those processes, which means that the conventional approach of making specific genes more active to boost yields would not solve the problem. Instead, researchers led by IRP senior investigator Joseph Shiloach, Ph.D., aimed to short-circuit the stress response entirely by suppressing a few key genes that become more active when microbial cells experience stress.

a microbial fermentation tank in Dr. Shiloach's lab

Dr. Shiloach’s team grows a variety of microbial and other types of cells in fermentation tanks like this one in order to figure out ways to make them better at synthesizing useful molecules.

“Traditionally, scientists have only looked at genes that become less active when growth slows down, and there are many genes like that, but it’s hard to improve the activity of all of those genes because there are so many,” says Ashish Sharma, Ph.D., a postdoctoral research fellow in Dr. Shiloach’s lab and the new study’s first author. “With our systems-level approach, we do just one or two genetic modifications and we get much better production.”

The IRP scientists tested this unconventional strategy in E. coli bacteria. Decades of research have produced detailed maps of how all the different genes in E. coli influence one another, as well as which genes become more or less active when E. coli are forced to produce substances they don’t naturally make. This knowledge allowed the IRP team to focus only on genes that become more active in that situation and that do not regulate other genes, which makes the consequences of manipulating them easier to track. The researchers examined the effects of deleting each one of these genes individually in E. coli that had been genetically engineered to produce a glowing green protein called green fluorescent protein (GFP), and they discovered that eliminating many of these genes dramatically boosted the amount of GFP each bacterial cell produced, sometimes by more than 250 percent.

bacteria

More From the IRP
Blog
Mouth Microbes Turn Treasonous in Gum Disease

In a second set of experiments, the IRP team took a list of the ten single-gene deletions that boosted yields the most and created additional strains of E. coli that each lacked a different pair of those genes, for a total of 45 different combinations. They repeated that experiment twice: once with E. coli designed to make GFP and once with E. coli designed to make a more complex molecule called L-asparaginase that is used to treat acute lymphoblastic leukemia, a type of blood and bone marrow cancer. Some of the combinations of gene deletions increased yields more than any of the single-gene deletions, although others actually hindered production. Seeing higher yields of L-asparaginase was particularly good news because, unlike GFP, L-asparaginase is secreted from cells after it is made rather than building up inside them.

Dr. Sharma (left) and Dr. Shiloach in their lab.

“The cell has limited space inside it, so if something just accumulates inside the cell, eventually there’s no space left,” explains Dr. Sharma, “but if the modified bacteria over-produce proteins that are being exported out of the cell, then that shows the real ability of the cell to produce them.”

By combining this new strategy with existing practices for boosting microbial protein production, researchers could noticeably enhance the ability of E. coli to manufacture a wide array of medicines and chemicals for scientific and industrial use, thereby speeding up the process and lowering costs. Moreover, if scientists can identify the genes that trigger the stress response in mammalian cells, they could also apply the IRP researchers’ approach to boost production of the particularly complex molecules those cells are used to synthesize.

“Eventually, if you can come up with a cell that is a better producer, you can use it every time you need to produce a protein to see if you can get higher production,” says Dr. Shiloach. “You have a better producer in general.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.

References:

[1] A novel knock out strategy to enhance recombinant protein expression in Escherichia coli. Sharma AK, Shukla E, Janoti DS, Mukherjee KJ, Shiloach J. Microb Cell Fact. 2020 Jul 23;19(1):148. doi: 10.1186/s12934-020-01407-z.


Category: IRP Discoveries
Tags: Test Tube Tuesday, microbes, microbiology, bacteria, genes, gene, genetics, DNA, leukemia, stress, metabolism

Related Blog Posts

  • Mosquitos With Human Gene Hinder Malaria Transmission
  • Dog Genome Yields Clues to Human Cancer
  • Scientists Douse Fat Burning to Combat Cancer
  • A Multi-Front Effort to Combat Coronavirus
  • Gene Editing Reveals Potential Cancer Treatment Target

This page was last updated on Tuesday, January 30, 2024

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search